SANGUINE Trademark

Trademark Overview


On Friday, July 21, 2023, a trademark application was filed for SANGUINE with the United States Patent and Trademark Office. The USPTO has given the SANGUINE trademark a serial number of 98097005. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Tuesday, July 2, 2024. This trademark is owned by Sanguine Biosciences, Inc.. The SANGUINE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Laboratory analysis in the field of biospecimens including cell analysis assays including but not limited to cell count, immunophenotyping, infectious disease testing, HLA typing for use in research; Laboratory research in the field of biospecimens including cell analysis assays including but not limited to cell count, immunophenotyping, infectious disease testing, HLA typing for use in research; Compiling data for research purposes in the field of medical science and medical consultancy; Medical and scientific research in the fields of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, and immunology for purposes including biomarker discovery and validation, drug discovery and development, diagnostics development, and other translational research.; Providing an on-line searchable database in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, immunology and health for scientific researc...
sanguine

General Information


Serial Number98097005
Word MarkSANGUINE
Filing DateFriday, July 21, 2023
Status645 - FINAL REFUSAL - MAILED
Status DateTuesday, July 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesLaboratory analysis in the field of biospecimens including cell analysis assays including but not limited to cell count, immunophenotyping, infectious disease testing, HLA typing for use in research; Laboratory research in the field of biospecimens including cell analysis assays including but not limited to cell count, immunophenotyping, infectious disease testing, HLA typing for use in research; Compiling data for research purposes in the field of medical science and medical consultancy; Medical and scientific research in the fields of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, and immunology for purposes including biomarker discovery and validation, drug discovery and development, diagnostics development, and other translational research.; Providing an on-line searchable database in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, immunology and health for scientific research purposes; Providing an on-line searchable database in the field of biospecimen and data collection for scientific research purposes; Providing information about medical research in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, and immunology for purposes including biomarker discovery and validation, drug discovery and development, diagnostics development, and other translational research; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Scientific laboratory services; Scientific research for medical purposes in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, and immunology for purposes including biomarker discovery and validation, drug discovery and development, diagnostics development, and other translational research; Scientific research in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, oncology and health research; providing biospecimen collection and data collection for scientific research purposes in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, and immunology for purposes including biomarker discovery and validation, drug discovery and development, diagnostics development, and other translational research

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeP - NOT AVAILABLE
Class Status DateMonday, August 21, 2023
Primary Code042
First Use Anywhere DateMonday, November 30, 2009
First Use In Commerce DateMonday, November 30, 2009

Trademark Owner History


Party NameSanguine Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWoburn, MA 01801

Trademark Events


Event DateEvent Description
Tuesday, July 25, 2023NEW APPLICATION ENTERED
Monday, August 21, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 25, 2024ASSIGNED TO EXAMINER
Monday, March 25, 2024REMOVED FROM TEAS PLUS
Monday, March 25, 2024NON-FINAL ACTION WRITTEN
Monday, March 25, 2024NON-FINAL ACTION E-MAILED
Monday, March 25, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 12, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 12, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 12, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 2, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, July 2, 2024FINAL REFUSAL WRITTEN
Tuesday, July 2, 2024FINAL REFUSAL E-MAILED